Table 5. Sensitivity, specificity, positive- and negative predictive value of PD-L1 expression for diagnosis of malignancy and N-status.
+ | - | sensitivity | specificity | positive predictive value | negative predictive value | ||
---|---|---|---|---|---|---|---|
PD-L1_4 tissue | |||||||
Diagnose | controls | 6 | 29 | ||||
(tissue) | patients | 35 | 8 | 81.4% | 82.9% | 0.854 | 0.784 |
PD-L1_2 tissue | |||||||
controls | 8 | 23 | |||||
patients | 32 | 11 | 74.4% | 74.2% | 0.8 | 0.68 | |
PD-L1_4 blood | |||||||
N-status | N0 | 11 | 13 | ||||
(blood) | N+ | 17 | 1 | 94.4 % | 54.2 % | 0.607 | 0.929 |
PD-L1_2 blood | |||||||
N0 | 8 | 16 | |||||
N+ | 15 | 3 | 83.3% | 66.7% | 0.652 | 0.842 |
The table shows sensitivity, specificity, positive- and negative predictive value of PD-L1 expression in tissue specimens for diagnosis of malignancy. (controls vs. patients) and of PD-L1 expression in blood samples for diagnosis of a positive N-status (N0 vs. N+).